Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 5/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 5/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | ACACA | Q13085 | 1/20 | 0.39 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | PLAU | P00749 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.37 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13385084 | 0.85 | PDK2 (0.52) | CYP11B1CYP11B2PDK2NPC1RAB9A | |
| SCHEMBL431270 | 0.84 | CYP11B2 (0.58) | CYP11B1CYP11B2PDK2NPC1RAB9A | |
| SCHEMBL12865702 | 0.83 | PDK2 (0.50) | CYP11B1CYP11B2PDK2NPC1RAB9A | |
| SCHEMBL12393750 | 0.81 | PDK2 (0.57) | CYP11B1CYP11B2PDK2NPC1RAB9A | |
| SCHEMBL12393752 | 0.81 | PDK2 (0.57) | CYP11B1CYP11B2PDK2NPC1RAB9A | |
| SCHEMBL17151289 | 0.81 | CYP1A2 (0.43) | CYP11B1CYP11B2PDK2NPC1RAB9A | |
| SCHEMBL12873471 | 0.80 | PDK2 (0.43) | PDK2ALOX5NPC1RAB9AACACA | |
| SCHEMBL464575 | 0.80 | CYP1A2 (0.53) | CYP11B1CYP11B2PDK2NPC1RAB9A | |
| SCHEMBL10068658 | 0.80 | CYP1A2 (0.53) | CYP11B1CYP11B2PDK2NPC1RAB9A | |
| SCHEMBL12865688 | 0.79 | PDK2 (0.53) | CYP11B1CYP11B2PDK2ACACACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9240553-B2 | Indeno[1,2-b]phenanthrene compound and organic light emitting element including the same | CANON KABUSHIKI KAISHA (JP) | 2016-01-19 | — | — | US | disclosed |
| US-20150255727-A1 | INDENO[1,2-b]PHENANTHRENE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2015-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150255727-A1 | INDENO[1,2-b]PHENANTHRENE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | CYP1A1, CYP1B1, AHR | CYP11B1 119/4885CYP11B2 147/4885PDK2 3965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.